as 09-18-2025 12:32pm EST
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Founded: | 1958 | Country: | United States |
Employees: | N/A | City: | IRVINE |
Market Cap: | 45.5B | IPO Year: | 2000 |
Target Price: | $85.74 | AVG Volume (30 days): | 3.9M |
Analyst Decision: | Buy | Number of Analysts: | 19 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 7.02 | EPS Growth: | 188.09 |
52 Week Low/High: | $64.00 - $83.00 | Next Earning Date: | 10-23-2025 |
Revenue: | $5,685,100,000 | Revenue Growth: | 9.14% |
Revenue Growth (this year): | 13.25% | Revenue Growth (next year): | 9.76% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Chopra Daveen | EW | CVP, TMTT | Aug 25 '25 | Sell | $81.95 | 2,500 | $204,865.00 | 30,996 | |
Wood Larry L | EW | Global President TAVR & Surg | Aug 18 '25 | Sell | $78.06 | 8,950 | $698,679.07 | 206,900.391 |
EW Breaking Stock News: Dive into EW Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
Simply Wall St.
3 days ago
GlobeNewswire
8 days ago
Insider Monkey
8 days ago
Medical Device Network
13 days ago
Zacks
14 days ago
MedTech Dive
15 days ago
Insider Monkey
16 days ago
The information presented on this page, "EW Edwards Lifesciences Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.